Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 425

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 4
Chunk 425
---
 operations$7,741 $7,448 $7,313 

(1)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.

Reconciliation of Shareholders' Net Income (GAAP) to Adjusted Income from OperationsFor the Years Ended December 31,202420232022(Diluted earnings per share)Pre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxShareholders' net income$12.12 $17.39 $21.41 Adjustments to reconcile to adjusted income from operationsNet investment losses (1)$8.95 8.93 $0.45 0.38 $1.96 1.59 Amortization of acquired intangible assets6.01 4.76 6.13 4.77 5.99 4.30 Special itemsIntegration and transaction-related costs0.97 0.75 0.15 0.12 0.43 0.33 Impairment of dividend receivable 0.64 0.49 — — — — Deferred tax expenses (benefits), net— 0.30 — (3.61)— — Net (gain) loss on sale of businesses (0.08)(0.02)5.05 4.81 (5.31)(4.26)Charge for organizational efficiency plan— — 0.85 0.65 0.07 0.05 Charges (benefits) associated with litigation matters— — 0.68 0.58 (0.09)(0.06)Total special items$1.53 1.52 $6.73 2.55 $(4.90)(3.94)Adjusted income from operations$27.33 $25.09 $23.36 

(1)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.

40